Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug

In a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP in the strengths of 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg.

Read Full Article on Economic Times

Enter your email address:

We will be happy to hear your thoughts

      Leave a reply

      IndiaClicking - Buzzing News & Stocks